Close
Back to CWBR Stock Lookup
Pages: 1 2 3 4 5 6 »» Last Page

CohBar (CWBR) –

Dec 27, 2023 09:02 AM Form 25-NSE CohBar, Inc. Filed by: Nasdaq Stock Market LLC
Nov 27, 2023 06:05 PM CohBar (CWBR) Announces Suspension of Trading, Upcoming Delisting
Nov 27, 2023 06:05 PM CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)
Nov 27, 2023 05:21 PM Form 8-K CohBar, Inc. For: Nov 20
Nov 13, 2023 09:06 AM Form 8-K CohBar, Inc. For: Nov 06
Nov 1, 2023 09:06 AM Form 8-K CohBar, Inc. For: Nov 01
Oct 25, 2023 09:02 AM Form 425 CohBar, Inc. Filed by: CohBar, Inc.
Oct 25, 2023 09:01 AM Form 8-K CohBar, Inc. For: Oct 25
Oct 11, 2023 11:24 AM Form SEC STAFF LETTER CohBar, Inc.
Oct 11, 2023 11:24 AM Form SEC STAFF LETTER CohBar, Inc.
Oct 6, 2023 04:14 PM Form 425 CohBar, Inc. Filed by: CohBar, Inc.
Oct 6, 2023 04:12 PM Form 8-K/A CohBar, Inc. For: Oct 04
Oct 4, 2023 09:14 AM Form 425 CohBar, Inc. Filed by: CohBar, Inc.
Oct 4, 2023 09:13 AM Form 8-K CohBar, Inc. For: Oct 04
Sep 13, 2023 06:04 AM Form EFFECT CohBar, Inc.
Sep 12, 2023 04:49 PM Form 424B3 CohBar, Inc.
Sep 12, 2023 01:46 PM Form S-4/A CohBar, Inc.
Aug 30, 2023 06:04 AM Form S-4/A CohBar, Inc.
Aug 14, 2023 04:08 PM Form 10-Q CohBar, Inc. For: Jun 30
Aug 14, 2023 04:06 PM Form 8-K CohBar, Inc. For: Aug 14
Aug 14, 2023 04:01 PM CohBar Reports Second Quarter 2023 Financial Results
Aug 10, 2023 05:32 PM Form S-4/A CohBar, Inc.
Jul 3, 2023 06:06 AM Form S-4 CohBar, Inc.
Jun 5, 2023 11:12 AM Form 425 CohBar, Inc. Filed by: CohBar, Inc.
Jun 5, 2023 08:05 AM Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (
May 31, 2023 04:51 PM Form 425 CohBar, Inc. Filed by: CohBar, Inc.
May 30, 2023 08:05 AM Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2023 04:36 PM U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.69%
May 23, 2023 07:56 AM Form 425 CohBar, Inc. Filed by: CohBar, Inc.
May 23, 2023 07:53 AM Form 8-K CohBar, Inc. For: May 22
May 23, 2023 07:32 AM CohBar (CWBR) and Morphogenesis, Inc. Enter into Definitive Merger Agreement
May 23, 2023 07:30 AM CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunoth
May 23, 2023 07:30 AM CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunoth
May 23, 2023 07:25 AM CohBar (CWBR) Halted, News Pending
May 15, 2023 08:33 AM Form 10-Q CohBar, Inc. For: Mar 31
Apr 28, 2023 09:01 AM Form 10-K/A CohBar, Inc. For: Dec 31
Mar 9, 2023 04:12 PM Form 10-K CohBar, Inc. For: Dec 31
Feb 8, 2023 09:01 AM Form SC 13G/A CohBar, Inc. Filed by: Barzilai Nir Yacov
Feb 8, 2023 09:01 AM Form SC 13G/A CohBar, Inc. Filed by: Cohen Pinchas
Dec 13, 2022 11:48 AM CohBar (CWBR) granted FDA orphan drug designations for treatment of idiopathic pulmonary fibrosis (IPF)
Dec 7, 2022 09:00 AM Form 8-K CohBar, Inc. For: Dec 07
Nov 17, 2022 08:48 AM CohBar (CWBR) retained Ladenburg Thalmann & Co. Inc. as a financial advisor to assist the Company in exploring strategic alternatives
Nov 17, 2022 08:31 AM Form 8-K CohBar, Inc. For: Nov 17
Nov 8, 2022 04:46 PM Form 10-Q CohBar, Inc. For: Sep 30
Nov 8, 2022 04:09 PM Form 8-K CohBar, Inc. For: Nov 08
Nov 8, 2022 04:03 PM CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Nov 8, 2022 04:03 PM CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Oct 26, 2022 09:00 AM CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
Oct 26, 2022 09:00 AM CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
Sep 29, 2022 01:18 PM CohBar (CWBR) granted Australian patent for obesity, diabetes, cancer, and liver disease treatement - Patent Grants
Pages: 1 2 3 4 5 6 »» Last Page

Back to CWBR Stock Lookup